New pill aims to help men last longer in bed
NCT ID NCT07047404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new drug called BP1.4979 can help men with lifelong premature ejaculation last longer during sex. Sixty men aged 18 to 50 will take either the drug or a placebo before sex for 12 weeks. Researchers will measure ejaculation time and check for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BP1.4979 (a dopamine D3 partial agonist)
- What this could lead to
- If it works, this could lead to a new on-demand treatment for primary premature ejaculation, giving men more control and longer time to ejaculation.
- What could go wrong
- This is an early Phase 2 trial with only 60 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE (EARLY) EJACULATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Nîmes
RECRUITINGNîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.